Stocks
BridgeBio Pharma, Inc.BBIO
NASDAQHealthcareBiotechnology$69.41+2.10%
Focused on developing therapies for genetic diseases, the company operates a network of subsidiary programs that advance drug candidates from early research through late-stage clinical development. Its pipeline includes treatments targeting rare cardiovascular, dermatologic, and metabolic disorders,...
Market Cap: $13.5B52W Range: $28.32 – $84.94
Congressional Interest in BridgeBio Pharma, Inc. (BBIO)
3 members of Congress have disclosed 5 trades in BridgeBio Pharma, Inc. (BBIO), a Healthcare company. The buy/sell breakdown shows 5 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
5
Unique Politicians
3
Buys
5
Sells
0
Who in Congress Is Trading BBIO?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-09-22 | Gilbert Cisneros | buy | $1K – $15K |
| 2025-08-08 | Gilbert Cisneros | buy | $1K – $15K |